Funding announced for Cambridge Cancer Research Hospital

The government has committed to provide funding for the new Cambridge Cancer Research Hospital at Addenbrooke’s.
Prime Minister Boris Johnson announced the funding on Friday 2nd October as part of the Health Infrastructure Plan, committing £3.7 billion for 40 hospitals across England.
The research hospital will bring together the clinical expertise of Cambridge University Hospitals with the scientific expertise of the University of Cambridge and the Cancer Research UK Cambridge Major Centre.
Professor Richard Gilbertson, Director of the CRUK Cambridge Centre and Group Leader at the Institute said: “I would like to take the opportunity to thank all those involved in the incredible partnership between the CRUK Cambridge Centre, Cambridge University Hospitals NHS Trust and the University that has made this possible.”
Today’s announcement gives a true ‘green light’ to the building of this much needed facility for our patients.”
Roland Sinker, CEO Cambridge University Hospitals, said: “We welcome the Prime Minister’s funding announcement for the Cambridge Cancer Research Hospital. Cambridge Cancer will rewrite the story of cancer; it will bring together world-class clinicians from Addenbrooke’s Hospital with cutting-edge Cambridge research and industry, enabling early detection of cancer and delivering bespoke, precision treatments that will radically improve patient outcomes.
“This national facility will bring hope for cancer patients regionally, nationally and internationally, and we look forward to progressing this project at a rapid pace.”
Related News
See all news-
Study looks at radiotherapy to treat and diagnose children’s brain tumours and avoid invasive surgery
3rd April 2025
A world first Cancer Research UK study is looking at radiotherapy to treat and diagnose children’s brain tumours and avoid invasive surgery.
Find out more -
Tony Davidge Shortlisted for National Papin Award for Outreach
31st March 2025
Tony’s nomination recognises his longstanding commitment to openness around the use of animals in cancer research, and the crucial role this openness plays in fostering understanding and trust.
Read more -
Sir Shankar Balasubramanian elected Fellow of the AACR Academy
10th March 2025
Sir Shankar has been recognised for his pioneering research in nucleic acid chemistry and his key role in the development of next-generation sequencing technology.
Find out more